Answer
Yes, pneumonitis and pulmonary fibrosis have been reported during and after cyclophosphamide treatment, and pneumonitis may develop even years after treatment.
Sources for this answer
- Cyclophosphamide Seacross 500 mg powder for solution for injection/infusionSeacross Pharmaceuticals Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 2Document updated
Sources checked